Defunct Company
Total Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
458
NCT00500578
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
Phase: Phase 4
Role: Collaborator
Start: Feb 28, 2003
Completion: Jan 31, 2009
NCT02778386
Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2016
Completion: Dec 31, 2016
NCT03679364
An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam
Phase: N/A
Start: Jul 2, 2019
Completion: Aug 20, 2020